Mifepristone complications less than one percent?
That’s not what the data really show By Randall K. O’Bannon, Ph.D. NRL Director of Education & Research In the recent hearing at the U.S. Fifth Circuit Court on the U.S. Food and Drug Administration’s approval the abortion pill mifepristone, government lawyer Sarah Harrington claimed that “the rate of serious complications is well less than …
Continue reading "Mifepristone complications less than one percent?"